Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.41 is 10% above its 3-year average of 0.37, around the middle of its 3-year range (0.00–0.63).
As of the fiscal period ended Tuesday, June 30, 2026. 26.00% below its 12-month average of 0.55.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.41.
DEBT TO EQUITY RATIO
0.41
DEBT TO EQUITY RATIO AVG TTM
0.55
DEBT TO EQUITY RATIO AVG 3Y
0.37
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-26.00%
CURRENT VS 3Y AVG
+10.02%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.12
median of 647 covered companies
CURRENT VS SECTOR MEDIAN
+240.85%
vs the sector median at left
Baird Medical Investment Holdings Limited
Market Cap
$32.14M
Debt to Equity Ratio
0.41
TTM Avg
0.55
3Y Avg
0.37
5Y Avg
N/A
Market Cap
$31.89M
Debt to Equity Ratio
0.40
TTM Avg
0.38
3Y Avg
0.64
5Y Avg
2.44
Market Cap
$31.77M
Debt to Equity Ratio
0.50
TTM Avg
0.49
3Y Avg
0.49
5Y Avg
0.65
Market Cap
$32.76M
Debt to Equity Ratio
N/A
TTM Avg
0.89
3Y Avg
0.89
5Y Avg
0.89
Market Cap
$30.57M
Debt to Equity Ratio
0.01
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$31.20M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.03
Market Cap
$33.93M
Debt to Equity Ratio
0.11
TTM Avg
0.10
3Y Avg
0.11
5Y Avg
0.10
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Baird Medical Investment Holdings Limited (BDMD) | $32.14M | 0.41 | 0.55 | 0.37 | N/A |
| HeartBeam, Inc. (BEAT)vs › | $32.43M | 0.00 | 0.00 | 0.00 | 0.00 |
| Rockwell Medical, Inc. (RMTI)vs › | $31.89M | 0.40 | 0.38 | 0.64 | 2.44 |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 0.50 | 0.49 | 0.49 | 0.65 |
| EUDA Health Holdings Limited (EUDA)vs › | $32.76M | N/A | 0.89 | 0.89 | 0.89 |
| Context Therapeutics Inc. (CNTX)vs › | $30.57M | 0.01 | 0.00 | 0.00 | 0.00 |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.20M | 0.00 | 0.00 | 0.00 | 0.03 |
| MDxHealth S.A. (MDXH)vs › | $30.82M | N/A | 4.88 | 3.59 | 2.94 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.93M | 0.11 | 0.10 | 0.11 | 0.10 |
| BeyondSpring Inc. (BYSI)vs › | $30.32M | N/A | 0.09 | 0.08 | 0.06 |
Debt/Equity
0.41
Current Ratio
1.29
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.41 |
| 2025-12-31 | 0.62 |
| 2025-06-30 | 0.63 |
| 2024-12-31 | 0.53 |
| 2024-06-30 | 0.40 |
| 2023-12-31 | 0.00 |
| 2023-06-30 | 0.02 |
